{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:36:48Z","timestamp":1792017408429,"version":"4.4.0"},"reference-count":46,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.1080\/14656566.2021.1939678","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T22:54:52Z","timestamp":1622847292000},"page":"1661-1667","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne"],"prefix":"10.1080","volume":"22","author":[{"given":"Veronica K.","family":"Emmerich","sequence":"first","affiliation":[{"name":"Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin G.","family":"Purvis","sequence":"additional","affiliation":[{"name":"Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina"},{"name":"Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina"},{"name":"Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston- Salem, North Carolina"},{"name":"Department of Dermatology, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12149"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04290.x"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.12.1584"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2016.1145338"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.037"},{"issue":"1","key":"cit0006","first-page":"1","volume":"17","author":"Dunn LK","year":"2011","journal-title":"Dermatol Online J"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2008.07053"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.10.060"},{"issue":"2","key":"cit0009","first-page":"103","volume":"86","author":"Yentzer BA","year":"2010","journal-title":"Cutis"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.2147\/ciia.2006.1.4.327"},{"issue":"12","key":"cit0011","first-page":"s51","volume":"17","author":"Chien A","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"cit0012","first-page":"417","volume":"82","author":"Leyden JJ","year":"2008","journal-title":"Cutis"},{"key":"cit0013","unstructured":"Tolaymat L, Zito PM Adapalene. statpearls. Treasure Island (FL) 2021."},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70055-0"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01371.x"},{"key":"cit0016","volume-title":"21st List, 2019","author":"World Health Organization Model List of Essential Medicines","year":"2019"},{"key":"cit0017","unstructured":"Matin T, Goodman MB Benzoyl peroxide. StatPearls. Treasure Island (FL) 2021."},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70440-2"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2008.x"},{"key":"cit0020","unstructured":"Epiduo (adapalene and benzoyl peroxide) gel, 0.1%\/2.5% prescribing information. Silver Spring, MD: U.S. Food and Drug Administration; 2008."},{"key":"cit0021","volume-title":"0.3%\/2.5% prescribing information. Silver Spring, MD: U.S","author":"Epiduo Forte (adapalene and benzoyl peroxide) gel","year":"2015"},{"issue":"4","key":"cit0022","first-page":"621","volume":"3","author":"Piskin S","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1037"},{"key":"cit0024","unstructured":"PubChem Compound Summary for CID 60164, Adapalene [Internet]. National Center for Biotechnology Information. [cited 2021 Mar 17]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Adapalene."},{"key":"cit0025","unstructured":"PubChem Compound Summary for CID 7187, Benzoyl peroxide [Internet]. national center for biotechnology information. [cited 2021 Mar 17]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Benzoyl-peroxide."},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.02.003"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.3109\/09546631003681094"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464130-00005"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70209-4"},{"key":"cit0030","unstructured":"A study to demonstrate the efficacy and safety of adapalene\/benzoyl peroxide topical gel in subjects with acne vulgaris [Internet]. U.S. National Library of Medicine. 2007. [cited 2021 Mar 9]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00421993."},{"key":"cit0031","unstructured":"Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%\/CD1579 2.5 % topical gel in acne vulgaris [Internet]. U.S. National Library of medicine. 2013. [cited 2021 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01880320."},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0178-4"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14026"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0352-y"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2048.x"},{"issue":"7","key":"cit0036","first-page":"657","volume":"8","author":"Fakhouri T","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"cit0037","unstructured":"Epiduo Forte (adapalene\/benzoyl peroxide, 0.3%\/2.5%) gel pediatric postmarketing pharmacovigilance review. U.S. Food and Drug Administration; 2017."},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0203-4"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1159\/000502575"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1159\/000362809"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00320-7"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-020-00108-9"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb07847.x"},{"issue":"2","key":"cit0044","first-page":"94","volume":"85","author":"Gold LS","year":"2010","journal-title":"Cutis"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10374.x"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1473837"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2021.1939678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T03:22:53Z","timestamp":1631676173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2021.1939678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,9,2]]}},"alternative-id":["10.1080\/14656566.2021.1939678"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2021.1939678","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}